Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweetsMarketScreener Strategies
The feature you requested does not exist. However, we suggest the following feature:

EUROPE MARKETS: European Markets Rally On Upbeat Data, Trade-talk Hopes

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/11/2018 | 03:20pm CET

By Barbara Kollmeyer, MarketWatch , Emily Horton

Trade headlines also inspire gains

European markets got into rally mode on Tuesday, boosted by upbeat economic data out of the region's biggest economy, and positive signals on the global trade front.

Pharmaceuticals, oil and auto stocks were driving the gains.

What did markets do?

   The Stoxx Europe 600   surged nearly 2% to 342.05, after closing down 1.8% on Monday. 

Germany's DAX 30 rose by 1.9% to 10,822.03, while France's CAC was up by the same amount, to 4,833.20.

The U.K.'s FTSE 100 jumped 1.7% to 6,835.92 , and Italy's FTSE MIB Italy index gained 1.5% to 18,679.71.

The euro was stronger versus the U.S. dollar, fetching $1.1383, up from $1.1358 late Monday in New York. The British pound rose to $1.2608 from $1.2561.

What is driving the markets?

President Donald Trump tweeted Tuesday (https://twitter.com/realDonaldTrump/status/1072480983683870720) that the U.S. was engaged in "very productive conversations" with China. A fresh round of trade talks kicked off late Monday via a phone call between Treasury Secretary Steven Mnuchin, U.S. Trade Representative Robert Lighthizer and Chinese Vice Premier Liu He, according to The Wall Street Journal (https://www.wsj.com/articles/u-s-china-trade-talks-get-under-way-11544498812).

Along those lines, auto stocks in Europe and the U.S. surged after a report from Bloomberg News (https://www.bloomberg.com/news/articles/2018-12-11/china-is-said-to-move-on-u-s-car-tariff-cut-trump-tweeted-about) that the Chinese government is reviewing a proposal to cut tariffs on U.S. made autos to 15% from 40%.

Cheer on the European economic front also lifted investor spirits. The ZEW economic research institute reported that German economic expectations rose in December , though they remained below the long-term average. Those expectations came in above forecasts.

And in France, markets got a lift after President Emmanuel Macron announced plans to cut taxes and lift wages for workers (https://www.wsj.com/articles/macron-pledges-tax-cuts-minimum-wage-hike-to-placate-protests-1544474039?mod=searchresults&page=1&pos=9), in a bid to calm the civil unrest that has been gripping Paris and other cities.

The pound recovered some after hitting its lowest level in more than a year on Monday after U.K. Prime Minister Theresa May delayed Tuesday's landmark parliamentary vote over the proposed Brexit deal. She plans to meet EU leaders in a bid to rescue the deal (https://news.google.com/articles/CBMiL2h0dHBzOi8vd3d3LmJiYy5jby51ay9uZXdzL3VrLXBvbGl0aWNzLTQ2NTE1NzQz0gF5aHR0cHM6Ly93d3ctYmJjLWNvLXVrLmNkbi5hbXBwcm9qZWN0Lm9yZy92L3Mvd3d3LmJiYy5jby51ay9uZXdzL2FtcC91ay1wb2xpdGljcy00NjUxNTc0Mz9hbXBfanNfdj0wLjEjd2Vidmlldz0xJmNhcD1zd2lwZQ?hl=en-GB&gl=GB&ceid=GB%3Aen).

What stocks are active?

Pharmaceutical stocks gained ground, with Novartis (NOVN.EB) climbing 2.7%, Novos Nordisk AS (NOVO-B.KO) climbed 1.2%.

Advertising giant WPP rose by almost 5%, after the company said it will simplify its structure in an effort to pursue savings goals by 2021.

Ashtead Group, the equipment rental company, climbed nearly 3% on the news of a profit rise and positive expectations for their year-end results .

Among autos, Daimler and BMW AG (BMW.XE) each jumped 3.3%,

Stocks mentioned in the article
ChangeLast1st jan.
ASHTEAD GROUP 5.23% 1689 Delayed Quote.-19.35%
BAYERISCHE MOTOREN WERKE 2.14% 71.54 Delayed Quote.-19.27%
DAIMLER 3.50% 47.055 Delayed Quote.-35.78%
DAX 1.86% 10809.72 Delayed Quote.-17.77%
EURO STOXX 50 1.71% 3064.56 Delayed Quote.-12.71%
FTSE 100 INDEX 0.28% 7234.11 End-of-day quote.-5.90%
NOVARTIS 2.38% 86.94 Delayed Quote.3.06%
STOXX ITALY 45 (EUR) 0.53% 84.08 Delayed Quote.-14.04%
WPP GROUP 4.94% 844.8 Delayed Quote.-39.97%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NOVARTIS
03:20pEUROPE MARKETS: European Markets Rally On Upbeat Data, Trade-talk Hopes
DJ
01:22pNOVARTIS : Sandoz and Pear Therapeutics Obtain FDA Clearance for reSET-O to Trea..
AQ
10:41aNOVARTIS : Sandoz EpiPen rival will launch in Q1, with lower price tag
AQ
10:27aNOVARTIS : Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM..
AQ
12/10NOVARTIS : Sandoz and Pear Therapeutics Obtain FDA Clearance for reSET-O to Trea..
DJ
12/10NOVARTIS : Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM..
PU
12/10NOVARTIS : Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM..
GL
12/08NOVARTIS : data demonstrates consistent efficacy and tolerability of Kisqali® co..
AQ
12/07CORRECTION : Cheaper EpiPen Rival story
AQ
12/07ADAMIS PHARMACEUTICALS : Provides Update on the U.S. Launch of SYMJEPI
AQ
More news
News from SeekingAlpha
10:30aCONATUS : A Rare Investment For Opportunistic Investors 
12/10FDA clears Pear Therapeutics mobile app for opioid use disorder 
12/10Novartis' Kisqali extends PFS in late-stage breast cancer studies 
12/10CONATUS AND EMRICASAN IN NASH CIRRHO : The Overlooked Therapeutic Promise 
12/09Tencent Music, Starbucks And Under Armour In Focus (Stocks To Watch Podcast) 
Financials ($)
Sales 2018 52 254 M
EBIT 2018 12 339 M
Net income 2018 12 348 M
Debt 2018 14 754 M
Yield 2018 3,44%
P/E ratio 2018 15,88
P/E ratio 2019 21,49
EV / Sales 2018 4,47x
EV / Sales 2019 4,33x
Capitalization 219 B
Chart NOVARTIS
Duration : Period :
Novartis Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 94,5 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Vasant Narasimhan Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Werner Kirsch Chief Financial Officer
John Tsai Chief Medical Officer
Srikant Madhav Datar Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS3.06%218 721
JOHNSON & JOHNSON4.09%389 584
PFIZER21.26%257 520
ROCHE HOLDING LTD.0.30%215 316
MERCK AND COMPANY37.59%201 321
AMGEN11.61%123 678